Consensus DaVita Inc.

Equities

DVA

US23918K1088

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
147.1 USD -0.01% Intraday chart for DaVita Inc. +6.19% +40.44%

Evolution of the average Target Price on DaVita Inc.

Price target over the last 5 years

History of analyst recommendation changes

4e24dfb4c919a9de44fd4e8.lp8PPBigZUT1O_bxmKvx0Bk2NesJKhTz2xJVOTlEfSA.u9doWDWUBw6Sf4LJ2t25sVJac917HGXBlEohCFQsPkTF_ktRU_k6d6Vezg~a52460290c8faa37ec0b47476ea3468b
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating MT
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing MT
TD Cowen Adjusts Price Target on DaVita to $139 From $136 MT
UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating MT
Deutsche Bank Adjusts Price Target on DaVita to $145 From $135 MT
Barclays Adjusts Price Target on DaVita to $150 From $133 MT
Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating MT
Truist Securities Adjusts Price Target on DaVita to $135 From $130, Maintains Hold Rating MT
UBS Adjusts DaVita Price Target to $145 From $134, Maintains Buy Rating MT
UBS Adjusts DaVita Price Target to $134 From $113, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on DaVita to $130 From $120, Maintains Hold Rating MT
UBS Lowers DaVita Price Target to $113 From $142, Maintains Buy Rating MT
Deutsche Bank Adjusts DaVita Price Target to $90 From $113, Maintains Hold Rating MT
ANALYST RECOMMENDATIONS : Biogen, Booking, GSK, Papa John's, XPO... Our Logo
UBS Upgrades DaVita to Buy From Neutral, Adjusts Price Target to $142 From $100 MT
Truist Securities Adjusts DaVita Price Target to $115 From $100, Maintains Hold Rating MT
Bernstein Adjusts DaVita's Price Target to $100 From $88, Keeps Market Perform Rating MT
Truist Securities Adjusts Price Target on DaVita to $100 From $90, Maintains Hold Rating MT
Deutsche Bank Adjusts DaVita Price Target to $113 From $85, Maintains Hold Rating MT
TD Cowen Boosts Price Target on DaVita to $98 From $90, Maintains Market Perform Rating MT
BofA Securities Adjusts DaVita Price Target to $96 From $86, Maintains Underperform Rating MT
Fresenius jump up - FMC firm after quarterly figures DP
UBS Adjusts DaVita Price Target to $91 From $74, Maintains Neutral Rating MT
Cowen Raises DaVita's Price Target to $90 From $76, Maintains Market Perform Rating MT
Truist Securities Adjusts Price Target on DaVita to $90 From $84, Maintains Hold Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
147.1 USD
Average target price
142.2 USD
Spread / Average Target
-3.35%
High Price Target
169 USD
Spread / Highest target
+14.87%
Low Price Target
122 USD
Spread / Lowest Target
-17.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DaVita Inc.

Truist Securities
TD Cowen
Barclays
Deutsche Bank Securities
UBS
Bernstein
BofA Securities
Cowen
RBC Capital Markets
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. DVA Stock
  4. Consensus DaVita Inc.